Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze BCLI stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate BCLI investment potential.

What is BCLI stock price today?

Get real-time BCLI stock price, historical data, and price charts on Financhill. Track BCLI performance with our advanced analysis tools.

Is BCLI a good investment?

Evaluate BCLI investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy BCLI stock?

To buy BCLI stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of BCLI?

View detailed market capitalization data and company valuation metrics for BCLI on our comprehensive analysis page.

What is the P/E ratio of BCLI?

Use our fundamental analysis tools to view BCLI P/E ratio and compare valuation metrics with industry peers.

What are BCLI earnings?

View BCLI earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Brainstorm Cell Therapeutics, Inc. 10K Form

Sell

BCLI
Brainstorm Cell Therapeutics, Inc.

Last Price:

$0.60

Seasonality Move:

24.38%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-14	10Q	BCLI/Brainstorm Cell Therapeutics, Inc. Quarterly
2023-11-14	10Q	BCLI/Brainstorm Cell Therapeutics, Inc. Quarterly
2023-08-14	10Q	BCLI/Brainstorm Cell Therapeutics, Inc. Quarterly
2023-05-15	10Q	BCLI/Brainstorm Cell Therapeutics, Inc. Quarterly
2022-11-14	10Q	BCLI/Brainstorm Cell Therapeutics, Inc. Quarterly
2022-08-15	10Q	BCLI/Brainstorm Cell Therapeutics, Inc. Quarterly

Receive BCLI News And Ratings

See the #1 stock for the next 7 days that we like better than BCLI

BCLI Financial Statistics

Sales & Book Value

Annual Sales:	$0
Cash Flow:	$-1.1M
Price / Cash Flow:	0
Annual Sales:	$-0.70
Price / Book:	0

Profitability

EPS (TTM):	-1.46380
Net Income (TTM):	$-10.8M
Gross Margin:	$-240K
Return on Equity:	0%
Return on Assets:	-476.79%

Brainstorm Cell Therapeutics, Inc. Earnings Forecast

Key Brainstorm Cell Therapeutics, Inc. Financial Ratios

Per Share Earnings over the last 24 years have been positive in 13 years.

Brainstorm Cell Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	OTCM
Industry:	Biotechnology
Sector:	Health Care
Current Symbol:	BCLI
CUSIP:	10501E
Website:	brainstorm-cell.com

Debt

Debt-to-Equity Ratio:	-0.06
Current Ratio:	0.06
Quick Ratio:	0

Price-to-Earnings

Trailing P/E Ratio:	0
Forward P/E Ratio:	0

BCLI Technical Analysis vs Fundamental Analysis